Effects of Shenqi Xiangyi granules in advanced gastric cancer chemotherapy
Adjuvant therapy with Shenqixian granules may enhance the efficacy of simudizumab combined with FOLFOX4 chemotherapy in advanced gastric cancer and the immune function by increasing immune cell counts, making it a valuable option in clinical treatment.
Authors
- Xi Liang (ORCID: https://orcid.org/0000-0002-7580-5933)
- HaiTong Hao (ORCID: https://orcid.org/0009-0003-2010-2864)
- Ting Chen (ORCID: https://orcid.org/0000-0003-1725-7956)
- Yanan Chen (ORCID: https://orcid.org/0000-0001-5510-231X)
- Xue Han (ORCID: https://orcid.org/0000-0002-2162-378X)
- Yu Song (ORCID: https://orcid.org/0009-0006-1964-5281)
- Xiao-Jing Shi
Institutions
- Soochow University (CN)
- Zhangjiagang First People's Hospital (CN)
Publication Details
- Journal
- World Journal of Gastrointestinal Oncology
- Published
- 2024-12-11
- DOI
- https://doi.org/10.4251/wjgo.v17.i1.99272
- Primary Topic
- Cancer-related molecular mechanisms research
- Type
- article
- Field-Weighted Citation Impact
- 0.00